OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time Bid/Ask 03:40:44 2024-05-23 am EDT | ||
| 0.95 EUR / 1 EUR | +8.33% |
|
| Current month | +28.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 0.9 | -21.05% |
| 24-05-21 | 1.14 | +2.70% |
| 24-05-20 | 1.11 | -0.89% |
| 24-05-17 | 1.12 | +15.46% |
| 24-05-16 | 0.97 | +21.25% |
Delayed Quote Börse Stuttgart
Last update May 22, 2024 at 03:44 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG71B2 |
| ISIN | DE000GG71B25 |
| Date issued | 2024-04-25 |
| Strike | 132.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.2 € |
|---|---|
| Lowest since issue | 0.33 € |
| Spread | 0.05 € |
| Spread % | 5.00% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
- Stock Market
- Certificates
- Certificat
